Abstract
Cathepsin-A-related arteriopathy with strokes and leukoencephalopathy (CARASAL) is an acronym that describes an ultra-rare, hereditary, cerebral small vessel disease. The aim is to summarize current knowledge and recent findings concerning phenotype, genotype, pathogenesis, diagnoses, and treatment options of CARASAL. The method used in the study is a systematic literature review. CARASAL is clinically characterized by a wide range of predominantly central nervous system abnormalities. These include migraine, stroke with central facial palsy, facial pain, non-positional vertigo, cognitive dysfunction with impaired concentration and behavioral disinhibition, REM-sleep behavioral disorder, and depression. CARASAL is caused by point mutations in CTSA encoding cathepsin-A. Cathepsin-A is a carboxypeptidase that associates with the lysosomal enzymes b-galactosidase and neuraminidase, promoting their stabilization. In addition, cathepsin-A degradates endothelin-1. CARASAL is a primary microangiopathy with severe atherosclerosis of arterioles and secondary leukoencephalopathy. So far, 19 patients have been reported. The frequency of CARASAL patients will most likely increase in the future, as CARASAL may be more frequently recognized with the increasingly available methods for genetic testing and advanced imaging techniques. The phenotypic and genotypic spectrum of CARASAL needs to be more extensively investigated and animal models for the disease need to be generated. Currently, the outcome cannot be sufficiently assessed, as too few cases have been reported.
Similar content being viewed by others
References
Bugiani M, Kevelam SH, Bakels HS, Waisfisz Q, Ceuterick-de Groote C, Niessen HW, Abbink TE, Lesnik Oberstein SA, van der Knaap MS (2016) Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Neurology 87:1777–1786
Lynch DS, Brandão Rodrigues, de Paiva A, Zhang WJ, Bugiardini E, Freua F, Tavares Lucato L, Macedo-Souza LI, Lakshmanan R, Kinsella JA, Merwick A, Rossor AM, Bajaj N, Herron B, McMonagle P, Morrison PJ, Hughes D, Pittman A, Laurà M, Reilly MM, Warren JD, Mummery CJ, Schott JM, Adams M, Fox NC, Murphy E, Davagnanam I, Kok F, Chataway J, Houlden H (2017) Clinical and genetic characterization of leukoencephalopathies in adults. Brain 140:1204–1211
Hervé D, Chabriat H, Rigal M, Dalloz MA, Kawkabani Marchini A, De Lepeleire J, Fontaine B, Ceuterick-de Groote C, Alili N, Mine M, Delaforge A, Bousser MG, Guichard JP, Martin JJ, Gray F, Tournier-Lasserve E (2012) A novel hereditary extensive vascular leukoencephalopathy mapping to chromosome 20q13. Neurology 79:2283–2287
Hwang YT, Lakshmanan R, Davagnanam I, Thompson AGB, Lynch DS, Houlden H, Bajaj N, Eriksson SH, Bamiou DE, Warren JD (2017) Brainstem phenotype of cathepsin A-related arteriopathy with strokes and leukoence phalopathy. Neurol Genet 3:e165
Kolli N, Garman SC (2014) Proteolytic activation of human cathepsin A. J Biol Chem 289:11592–11600
Rudenko G, Bonten E, d’Azzo A, Hol WG (1995) Three dimensional structure of the human’protective protein’: structure of the precursor form suggests a complex activation mechanism. Structure 3:1249–1259
Bonten EJ, Annunziata I, d’Azzo A (2014) Lysosomal multienzyme complex: pros and cons of working together. Cell Mol Life Sci 71:2017–2032
Xie F, Zhang LS (2018) A chinese CARASIL patient caused by novel compound heterozygous mutations in HTRA1. J Stroke Cerebrovasc Dis 27:2840–2842
Yamazaki N, Kanazawa K, Kimura M, Ike H, Shinomiya M, Tanaka S, Shinohara Y, Minakawa N, Itoh K, Takiguchi Y (2018) Use of modified U1 small nuclear RNA for rescue from exon 7 skipping caused by 5′-splice site mutation of human cathepsin A gene. Gene 677:41–48
Fussiger H, Jardim LB, Saute JA (2017) Letter re: cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Neurology 88:1776
van der Knaap MS, Bugiani M, Kevelam SH (2017) Author response: cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Neurology 88:1776
Haffner C, Vinters HV (2016) CADASIL, CARASIL, CARASAL: the linguistic subtleties of cerebral small vessel disease. Neurology 87:1752–1753
Funding
No funding was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Finsterer, J., Scorza, C.A., Scorza, F.A. et al. Update on hereditary, autosomal dominant cathepsin-A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Acta Neurol Belg 119, 299–303 (2019). https://doi.org/10.1007/s13760-019-01158-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-019-01158-8